Currently Recruiting!
Who: Peri- or post-menopausal women ages 40-65, who are experiencing insomnia and hot flashes, and are at risk for diabetes
What: Clinical research study to investigate the efficacy of suvorexant on insomnia symptoms and on glycemic control in midlife pre-diabetic women with insomnia, and to learn whether improvement in insomnia symptoms is linked with improvement in glycemic control.
This research study will compare suvorexant to placebo. During the study, participants will get both placebo and suvorexant, each for 4 weeks during the study, with a 4-week time off study medication in between.
Study participation includes:
- 6 study visits, some of which are remote, over approximately 14 weeks
- Taking an FDA-approved medication or placebo daily for a total of 8 weeks
- Completing daily symptom diaries and other at-home data collection measures
- Recording meals and wearing a glucose monitor for 3 days/each, at 4 points during the study.
- Having 5 blood draws
Where: Brigham and Women’s Hospital, Boston MA.
Please note study participation includes 2 remote study visits, and up to 4 in-person study visits to the Hospital. Parking vouchers are provided for in-person study visits.
To see if you might be eligible to participate in this study, please complete this brief, online survey:
Click here for Pre-screen Survey
If you would like to speak with a Research Coordinator for this study, please email or call: wharp@bwh.harvard.edu; 617-525-9896
Participants may be compensated up to $800 for their time. Participants will not incur any study-related expenses.
